WELCOME TO JOHNS HOPKINS HEALTH ALERTS!

This free public service from Johns Hopkins Medicine helps keep you up to date on the latest breakthroughs for the most common medical conditions which prevent healthy aging. Browse all the articles via the Health Alert Topics navigation bar on the right, or read the headlines below.


Get the latest news sent straight to your Inbox. Register now for your FREE Johns Hopkins Health Alerts. Check the boxes below for all the topics you are interested in, enter your email address, and click "Send." It's fast, easy, and FREE.   Benefits of Being A Registered User

Enter your email here: (Example: yourname@domain.com)
Please send my alerts as:

We value your privacy and will never rent your email address.Already a Member? Manage your Health Alerts


Johns Hopkins Health Alert

Statin Drugs Protect Against Glaucoma

Comments (2)

  • Patients who had used statins for two years or longer were 40 percent less likely to develop glaucoma than those who had used the drugs for less time.

The long-term use of cholesterol-lowering drugs called statins (such as Zocor, Lipitor and Crestor) appears to reduce the risk of glaucoma among men, particularly those with cardiovascular disease and high cholesterol, according to recent research published in the Archives of Ophthalmology.

Statins have previously been linked to possible decreased risk of age-related macular degeneration, and there are sound scientific reasons why these drugs may also protect against glaucoma.

Researchers evaluated the medical records of 667 men age 50 or older who had recently developed glaucoma, then determined their statin use. For comparison, statin use was also recorded for 6,667 control subjects without glaucoma.

Patients who had used statins for two years or longer were 40 percent less likely to develop glaucoma than those who had used the drugs for less time. The benefits were most pronounced for men with cardiovascular disease and high cholesterol. A protective effect against glaucoma was also observed for non-statin anti-cholesterol drugs.

The researchers hypothesize that statins might reduce the risk of glaucoma directly, by reducing atherosclerosis in the optic nerve, or indirectly, by improving blood flow in the eye. Statins might also enhance the ability of cells in the trabecular meshwork (a spongy network of connective tissue located just in front of the iris) to drain excess fluid.

Posted in Vision on April 20, 2006
Reviewed June 2011


Medical Disclaimer: This information is not intended to substitute for the advice of a physician. Click here for additional information: Johns Hopkins Health Alerts Disclaimer


Notify Me

Would you like us to inform you when we post new Vision Health Alerts?

Post a Comment

Comments

Health Alerts registered users may post comments and share experiences here at their own discretion. We regret that questions on individual health concerns to the Johns Hopkins editors cannot be answered in this space.

The views expressed here do not constitute medical advice, and do not represent the position of Johns Hopkins Medicine or Remedy Health Media, LLC, which has no responsibility for any comments posted on this site.


Outstanding- very informative

Posted by: elina | June 10, 2006 3:04 AM

i havejust been advised that i have the beginning stage of glocoma and i have to have laser surgery n the mesh part of my eye to presure thefluid is locked. bwould statin drugs help in my case ..iwas advised by my regualar dr that my colestral was 240and he has subscribe crestor.. should this help my glocoma..i am a women 72 yrs

Posted by: malia | September 12, 2006 4:27 PM

Post a Comment


Already a subscriber?

Login

Forgot your password?

New to Johns Hopkins Health Alerts?

Register to submit your comments.

(example: yourname@domain.com)

(800) 829-0422

Registered Users Log-in:

Forgot Password?

Become a Registered User!
It's fast and FREE!
The Benefits of Being a Registered User

Health Topic Pages

  • Health Alert
  • Special Report

What is this?

XML


Johns Hopkins' Vision Bestsellers

Controlling Glaucoma to Prevent Vision Loss

Written by Harry A. Quigley, M.D., Director of the Dana Center for Preventive Ophthalmology at the acclaimed Wilmer Eye Institute at Johns Hopkins, Controlling Glaucoma to Prevent Vision Loss provides straightforward answers to your most important questions about managing glaucoma, a condition that affects an estimated 2.5 million Americans. Controlling Glaucoma to Prevent Vision Loss discusses everything you need to know about glaucoma: its possible causes, the current methods for diagnosing it, and the many options that you have to treat it, from eye drops to laser surgery. If you or a loved one has glaucoma, our new report will give you the information you need to make informed treatment decisions that could save your sight. Read more or order the INSTANT PDF DOWNLOAD

 


Johns Hopkins Vision White Paper 2011

2011 Vision White Paper
Written by Dr. Susan B. Bressler, professor of ophthalmology at the acclaimed Wilmer Eye Institute, and a team of top Johns Hopkins doctors, this comprehensive report is essential reading for anyone affected by a vision disorder, including low vision, cataracts, glaucoma, age-related macular degeneration, and diabetic retinopathy. 88 pages.
Read more or order the INSTANT PDF DOWNLOAD EDITION
Read more or order the PRINT EDITION




Johns Hopkins Diabetes White Paper 2011


2011 Diabetes White Paper
The Diabetes White Paper teaches you how to manage Type 1 and Type 2 diabetes and avoid complications, such as nerve damage, heart disease, kidney failure, and retinopathy. This comprehensive report explains the basics of how your body metabolizes glucose and reviews the latest medications and tools for monitoring your blood glucose. Includes diagrams, glossary, and recent research. 96 pages.
Read more or order the INSTANT PDF DOWNLOAD EDITION
Read more or order the PRINT EDITION